Immunotherapy in Melanoma: Where Are We Going From Here?

Department of Medicine Grand Rounds
Immunotherapy in Melanoma: Where Are We Going From Here?

Immunotherapy has transformed the treatment of melanoma. What's next in this quickly evolving field? This Grand Rounds will explore how immunotherapy agents work in melanoma and will highlight emerging molecules and innovative strategies shaping the next generation of melanoma treatment.

Adil Daud, MD, is Professor of Medicine in the Division of Hematology and Oncology at UCSF Health and co-director of The UCSF Helen Diller Family Comprehensive Cancer Center Melanoma Program. His research focuses on cancer immunotherapy, particularly in skin cancers and site-specific immunity. He has designed and conducted clinical trials related to melanoma treatment and has also developed novel immunotherapies to treat this cancer.

How to Attend: 
In Person: 
S-214, Medical Sciences Building (513 Parnassus Avenue) 
Lunch will be provided 

Zoom option: 
https://ucsf.zoom.us/j/97633865272?pwd=sHvIef57IXKYFnBm2lnvQtxUMeRVEn.1  
Webinar ID: 976 3386 5272 
Passcode: 609641 

Or join by phone (for higher quality, dial a number based on your current location): 
+1 669 900 6833 US (San Jose) 
+1 213 338 8477 US (Los Angeles) 
+1 669 219 2599 US (San Jose) 
+52 554 161 4288 (Mexico) 

International numbers available: https://ucsf.zoom.us/u/ac4WisOf7E  

New procedures for claiming CME credit:  
Please review this informational guide on the updated ways to claim CME credit starting in academic year 25-26.